Luminex logo

LMNX - Luminex News Story

$36.71 0.0  0.0%

Last Trade - 9:00pm

Sector
Healthcare
Size
Mid Cap
Market Cap £1.22bn
Enterprise Value £1.14bn
Revenue £299.7m
Position in Universe 2376th / 6852

BUZZ-Luminex: Rises as COVID-19 antibody test gets FDA's emergency use authorization

Fri 17th July, 2020 5:25pm
** Medical device maker's shares  LMNX.O  rise 8.2% to
$37.35 - on track for best day since March 24  
    ** The U.S. FDA, in a letter dated July 16, authorized
emergency use (EUA) of co's test to detect antibodies against
the new coronavirus (https://bit.ly/3fFfi98)
    ** The FDA says the test is intended to be used as an aid in
identifying those with an immune response to the new
coronavirus, which could indicate prior infection 
    ** Use of test limited to authorized laboratories 
    ** Co in April received EUA for a rapid virus detection test
 urn:newsml:reuters.com:*:nFWN2BU0UR
    ** Including session gains, stock up ~61%

 (Reporting by Manas Mishra in Bengaluru)
 ((Manas.Mishra@thomsonreuters.com;
www.twitter.com/Manasmishra24; within U.S. +1 646 223 8780,
outside U.S. +91 806749 2709;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.